ELAN in the 13F filings
Elanco Animal Health Inc · CUSIP 28414H103
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 29
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 5 listed it in both
- Shares listed
- 163,443,473
- combined, among listed positions
- Reported value
- $4.0bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 15 buyers (opened or added shares) and 15 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +16,048,291.
Managers listing ELAN in Q2 2026
29 of 29 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 56,948,819 shares now+6,023,453
- Citadel Advisors LLCexisting position · 9,668,611 shares now+5,281,484
- Marshall Wace LLPexisting position · 4,432,350 shares now+3,049,938
- Freestone Grove Partners LPnew position · 2,170,681 shares now+2,170,681
- Millennium Management LLCexisting position · 2,725,889 shares now+2,011,850
Reductions
- Invesco Ltdexisting position · 5,306,326 shares now-2,834,846
- T. Rowe Price Associates Incexisting position · 1,381,660 shares now-1,819,830
- Dodge & Coxexisting position · 67,397,025 shares now-1,547,075
- Capital World Investorsexisting position · 2,813,674 shares now-594,657
- Wellington Management Group LLPexisting position · 2,676,050 shares now-359,806
New positions and exits
New (7)
Exited (2)
- Walleye Capital LLCwas $339k
- Brevan Howard Capital Management LPwas $255k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2018 | 13 | $388m | n.a. | n.a. |
| Q4 2018 | 7 | $383m | n.a. | n.a. |
| Q1 2019 | 14 | $3.5bn | n.a. | n.a. |
| Q2 2019 | 10 | $3.7bn | n.a. | n.a. |
| Q3 2019 | 13 | $2.9bn | n.a. | n.a. |
| Q4 2019 | 13 | $3.3bn | n.a. | n.a. |
| Q1 2020 | 13 | $2.9bn | n.a. | n.a. |
| Q2 2020 | 12 | $2.4bn | n.a. | n.a. |
| Q3 2020 | 6 | $2.9bn | n.a. | n.a. |
| Q4 2020 | 16 | $4.1bn | n.a. | n.a. |
| Q1 2021 | 12 | $4.0bn | n.a. | n.a. |
| Q2 2021 | 14 | $4.6bn | n.a. | n.a. |
| Q3 2021 | 10 | $4.0bn | n.a. | n.a. |
| Q4 2021 | 13 | $3.8bn | n.a. | n.a. |
| Q1 2022 | 11 | $3.1bn | n.a. | n.a. |
| Q2 2022 | 11 | $2.4bn | n.a. | n.a. |
| Q3 2022 | 15 | $1.9bn | n.a. | n.a. |
| Q4 2022 | 15 | $1.7bn | n.a. | n.a. |
| Q1 2023 | 12 | $1.2bn | n.a. | n.a. |
| Q2 2023 | 13 | $1.6bn | n.a. | n.a. |
| Q3 2023 | 12 | $1.7bn | n.a. | n.a. |
| Q4 2023 | 9 | $1.9bn | 2 | 9 |
| Q1 2024 | 10 | $2.3bn | 7 | 3 |
| Q2 2024 | 9 | $2.1bn | 6 | 4 |
| Q3 2024 | 7 | $1.5bn | 4 | 3 |
| Q4 2024 | 5 | $1.5bn | 2 | 2 |
| Q1 2025 | 6 | $1.5bn | 4 | 1 |
| Q2 2025 | 9 | $2.5bn | 8 | 2 |
| Q3 2025 | 12 | $3.4bn | 7 | 5 |
| Q4 2025 | 9 | $3.3bn | 17 | 15 |
| Q1 2026 | 5 | $3.0bn | 15 | 16 |
| Q2 2026 | 10 | $3.6bn | 15 | 15 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ELAN and LLY →ELAN and JNJ →ELAN and VRTX →Choose a stock to compare with ELAN →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ELAN, latest filings →Back to the 13F Explorer →